Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ara 290 (2 trials)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Glucose Intolerance (Phase 2)
Prediabetic State (Phase 2)
Sarcoidosis (Phase 2)
Trials (2 total)
Trial APIs (1 total)